Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,763
archived clinical trials in
Colitis

Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated:  2/13/2013
Pfizer Investigational Site
mi
from
West Jordan, UT
Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
A Phase 2A, Randomized, Double-Blind, Sponsor Unblinded, Placebo-Controlled, Multiple Dose Study To Evaluate The Pharmacodynamics, Pharmacokinetics And Safety Of Anrukinzumab In Patients With Active Ulcerative Colitis
Status: Enrolling
Updated: 2/13/2013
Pfizer Investigational Site
mi
from
West Jordan, UT
Click here to add this to my saved trials
Optimal Surgical Treatment Of Fulminant Clostridium Difficile Colitis
Diverting Loop Ileostomy and Colonic Lavage: An Alternative To Total Abdominal Colectomy For The Treatment Of Fulminant Clostridium Difficile Colitis. A Randomized Controlled Trial.
Status: Enrolling
Updated:  2/23/2013
Massachusetts General Hospital
mi
from
Boston, MA
Optimal Surgical Treatment Of Fulminant Clostridium Difficile Colitis
Diverting Loop Ileostomy and Colonic Lavage: An Alternative To Total Abdominal Colectomy For The Treatment Of Fulminant Clostridium Difficile Colitis. A Randomized Controlled Trial.
Status: Enrolling
Updated: 2/23/2013
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated:  3/11/2013
Arkansas Children's Hospital
mi
from
Little Rock, AR
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated: 3/11/2013
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated:  3/11/2013
Advanced Clinical Research Institute
mi
from
Anaheim, CA
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated: 3/11/2013
Advanced Clinical Research Institute
mi
from
Anaheim, CA
Click here to add this to my saved trials
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated:  3/11/2013
University of California, San Francisco
mi
from
San Francisco, CA
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated: 3/11/2013
University of California, San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated:  3/11/2013
Connecticut Children's Medical Center
mi
from
Hartford, CT
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated: 3/11/2013
Connecticut Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated:  3/11/2013
University of Maryland Medical Center for Children
mi
from
Baltimore, MD
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated: 3/11/2013
University of Maryland Medical Center for Children
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated:  3/11/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Status: Enrolling
Updated: 3/11/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
Status: Enrolling
Updated:  3/12/2013
Santa Barbara Cottage Hospital
mi
from
Santa Barbara, CA
Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
Status: Enrolling
Updated: 3/12/2013
Santa Barbara Cottage Hospital
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated:  4/3/2013
Clinical Research Facility
mi
from
Glendale, CA
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated: 4/3/2013
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated:  4/3/2013
Clinical Research Facility
mi
from
Bridgeport, CT
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated: 4/3/2013
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated:  4/3/2013
Clinical Research Facility
mi
from
Danbury, CT
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated: 4/3/2013
Clinical Research Facility
mi
from
Danbury, CT
Click here to add this to my saved trials
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated:  4/3/2013
Clinical Research Facility
mi
from
Miami, FL
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated: 4/3/2013
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated:  4/3/2013
Clinical Research Facility
mi
from
Duncansville, PA
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated: 4/3/2013
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Orange, CA
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Roseville, CA
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Roseville, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Littleton, CO
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Littleton, CO
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Bristol, CT
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Bristol, CT
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Tampa, FL
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Fort Dodge, IA
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Fort Dodge, IA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Topeka, KA
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Louisville, KY
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
mi
from
Laurel, MD
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
mi
from
Laurel, MD
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Dearborn, MI
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Dearborn, MI
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Troy, MI
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Troy, MI
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Mexico, MO
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Mexico, MO
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
St. Louis, MO
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Lebanon, NH
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Lebanon, NH
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Great Neck, NY
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Huntington, NY
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Huntington, NY
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
New York, NY
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Charlotte, NC
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Kinston, NC
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Kinston, NC
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Cincinnati, OH
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Cleveland, OH
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Oklahoma City, OK
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Tulsa, OK
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Philadelphia, PA
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Charleston, SC
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Columbia, SC
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Germantown, TN
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Nashville, TN
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Austin, TX
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Galveston, TX
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Galveston, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Burlington, VT
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Burlington, VT
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Christiansburg, VA
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Christiansburg, VA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Richmond, VA
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Bellevue, WA
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Madison, WI
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  4/29/2013
Clinical Research Facility
mi
from
Milwaukee, WI
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 4/29/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials